ID: ALA128069

Max Phase: Preclinical

Molecular Formula: C20H19NO6

Molecular Weight: 369.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(C(=O)c2nc(O)cc3cc(OC)c(OC)cc23)cc1OC

Standard InChI:  InChI=1S/C20H19NO6/c1-24-14-6-5-11(7-15(14)25-2)20(23)19-13-10-17(27-4)16(26-3)8-12(13)9-18(22)21-19/h5-10H,1-4H3,(H,21,22)

Standard InChI Key:  SGMDPIGHJKCPHI-UHFFFAOYSA-N

Associated Targets(Human)

Insulin-like growth factor binding protein 3 46 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 369.37Molecular Weight (Monoisotopic): 369.1212AlogP: 3.21#Rotatable Bonds: 6
Polar Surface Area: 87.11Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.16CX Basic pKa: 1.08CX LogP: 3.25CX LogD: 3.25
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -0.03

References

1. Chen C, Zhu YF, Liu XJ, Lu ZX, Xie Q, Ling N..  (2001)  Discovery of a series of nonpeptide small molecules that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins.,  44  (23): [PMID:11689087] [10.1021/jm010304b]

Source